Clinical Trials
33 trialsPaclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
AIDS Malignancy Consortium
Doxil/Caelyx BE Study
Baxter Healthcare Corporation
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
Fred Hutchinson Cancer Center
Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Eastern Cooperative Oncology Group
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
National Cancer Institute (NCI)
SCART
Sheffield Teaching Hospitals NHS Foundation Trust
Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
AIDS Malignancy Consortium
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
National Cancer Institute (NCI)
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Eastern Cooperative Oncology Group
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
AIDS Malignancy Consortium
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Valproic Acid in Treating Patients With Kaposi's Sarcoma
AIDS Malignancy Consortium
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
National Cancer Institute (NCI)
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
National Cancer Institute (NCI)
Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
Washington University School of Medicine
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
Roswell Park Cancer Institute
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
Roswell Park Cancer Institute
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Pfizer
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Case Comprehensive Cancer Center
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Case Comprehensive Cancer Center